Lantis Laser Inc.

Lantis Laser Inc. (OTC: LLSR) is focused on developing its exclusive OCT Dental Imaging System™ for use in general dentistry under License from Lawrence Livermore National Laboratory and LightLab Imaging.

Lantis was formed to commercialize the application of novel technologies in the dental industry. The criteria for selected products include competitive edge, exclusivity and large market potential. The Company plans to launch the OCT Dental Imaging System™ in the third quarter of 2008 as its first product. Lantis has exclusive rights to the application of OCT technology in the field of dentistry under its license Agreements with Lawrence Livermore National Laboratory and LightLab Imaging. OCT was invented in the early 1990's at the Massachusetts Institute of Technology and is currently being commercialized by Carl Zeiss Meditec, Inc. in ophthalmology and by LightLab Imaging for cardiovascular imaging. In a press release on November 8th, 2006 Carl Zeiss Meditec AG announced the sale of its 6000th OCT Stratus System, initially introduced in 2002. At an approximate retail price of $65,000 per System, this generated almost $400 million in sales. LightLab Imaging is commercializing OCT for cardiovascular imaging with systems currently being sold in Europe, and entry in the near future into the US and Japanese markets.

OCT Dental Imaging System™ Development

The OCT Dental Imaging System™ is currently in Phase 2 development. The objective of Phase 2 is to build 5 Beta OCT Systems for clinical use prior to completing the final specification for the pre-production System. The Beta systems are expected to be built in approximately 6 months and will be placed in clinical use with leading clinicians and universities to provide characterization and histological data, in addition to user feedback for the final system specification. Clinical experience is expected to take up to 6 months. System development will include a new software suite to accommodate the high scanning speed and clinical software for image capture, manipulation and storage. The hand-held scanner will be optimized for “in-the-mouth” image capture.

Phase 3 will focus on finalizing the pre-production System specification, including final industrial design. The System will be sold in two configurations: firstly, for integration with other digital modalities such as dental x-ray, and secondly in a cart as a stand-alone System. FDA 510(k) clearance will be applied for in this Phase and this is typically obtained with a 90-day pre-market notification.

OCT Dental Imaging System™ vs. Standard X-Ray

Lantis Laser's OCT (Optical Coherence Tomography) Dental Imaging System™ has 10 times the resolution of the standard x-ray, providing much earlier detection of tooth decay than currently possible. It can also be used safely on children enabling the dentist to set in motion the necessary program to safeguard their oral health.

A long-standing problem in dentistry has been the inability for x-rays to image the decay in the pits and grooves of the biting surfaces of teeth where almost ninety percent of the decay begins. A major advancement in dental diagnostic imaging, not seen since the inception of x-rays in 1885, will soon be available for the dentist. Lantis' OCT Dental Imaging System™ will enable the dental profession to capture images of the occlusal (biting) and other surfaces and to make earlier and more accurate diagnosis of decay, before it shows up on x-ray, through the advanced technology use of safe, non-invasive light which is scanned over the tooth surface with a very small handheld probe. The captured cross-sectional images of the tooth can immediately be viewed on a chairside display monitor. OCT imaging is analogous to ultrasound, but uses light instead of sound and generates an image with up to 25 times the resolution.

OCT can also image soft tissue, which is not possible with x-ray, and the depth of periodontal pockets can be measured comfortably without physical probing to aid in the early detection of gum disease. OCT can aid in the early diagnosis of oral cancer without surgical removal of tissue as in a conventional biopsy, by imaging into affected tissue and doing what is known as an "Optical Biopsy".

OCT technology is ideal for use in dentistry as the handpiece scanner is used in the mouth, emitting no harmful radiation, as the OCT System is light-based. It is compact, easy to use and provides an actual image of the subject that can easily be read chairside.

Market Potential

The dental market is large and growing. Dental revenues in the US are approximately $80 billion growing annually at 7-9%. The number of dentists per 1000 population is decreasing as older dentists retire and dental schools are not increasing the number of graduates. Younger dentists are technologically adept, increasing the acceptance of advanced digital modalities.

In the U.S., dentists form the largest medical sub-group, with 140,000 practicing in 100,000 offices in 380,000 treatment rooms. Europe, Japan and other first world countries have at least another 100,000 offices. Based on the assumption that each office would purchase one OCT System, the world market can be estimated at 200,000 Systems. At the targeted maximum retail price of $20,000 the total potential market for the OCT System is estimated at $4 billion. Lantis believes it can achieve a market penetration of approximately 5%, or $200 million sales at retail over the first 4 years from when sales commence.

The immediate market potential for the OCT Dental Imaging System™ is the installed digital x-ray/camera base of approximately 50,000 units, representing approximately 25% of the dental offices, worldwide. New installations of digital x-ray/camera are expected to be 12,500 per year, worldwide. It is projected that OCT System sales will be 50% into the installed base, 45% as part of new installations and 5% as stand-alone Systems.

Disclosure: Pentony Enterprises LLC was compensated $27,000 and 70,000 restricted shares directly from the company and 55,000 free trading shares from a non controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. It is the policy of Pentony Enterprises LLC to sell all shares of this and any company featured. Anyone considering any company we feature in consideration for free trading shares should consider this. Pentony Enterprises no longer holds shares.

OCT Technology

What is OCT?

Optical Coherence Tomography (OCT) is a promising new class of diagnostic medical imaging technology that utilizes advanced photonics and fiber optics to obtain images and tissue characterization on a scale never before possible within the human body. When fully exploited, the technology has the potential to dramatically change the way physicians, researchers and scientists see and understand the human body in order to better diagnose and treat disease.

Simply put, OCT combines the principles of ultrasound with the imaging performance of a microscope and a form factor that is familiar to clinicians. Whereas ultrasound produces images from backscattered sound "echoes," OCT uses infrared light waves that reflect off the internal microstructure within the biological tissues. The frequencies and bandwidths of infrared light are orders of magnitude higher than medical ultrasound signals -- resulting in greatly increased image resolution - 8-25 times greater than any existing modality.

Infrared light is delivered to the imaging site through a single optical fiber only .006" diameter (about the size of the period in this sentence). The imaging guidewire contains a complete lens assembly to perform a variety of imaging functions. The guide wire can be deployed independently or integrated into a dental turbine or laser hand piece.

Light-based, non-radiating, high-resolution imaging of hard and soft tissue makes it ideal for use in dentistry with targeted introduction in 2008.

Advancements in Technology Application

OCT is a new diagnostic imaging technology that is based on the application of advanced photonics and fiber optics. It enables the capture of cross-sectional images of tissue with an axial resolution of ten times that of x-ray, providing tissue characterization and images that cannot be obtained by any other means, including x-ray.

While the light becomes scattered in the dense biological tissue, a certain component of the reflected light remains unscattered and thus contains good quantitative and structural image information. The OCT technology maps the changing intensities of reflections from the tissue to form an image of the subject area. This image, displayed on a monitor, has an unprecedented amount of diagnostic information and can be manipulated, printed out and stored in a digital format. OCT is ideal for application in imaging of the dental structures as it has the following characteristics:

• High Resolution: Current OCT systems have resolutions at 4-20 um compared with 50 microns for dental x-ray and 110 um for high frequency ultrasound.
• Tissue Characterization: Using information inherent to the returning photon signals, OCT can perform both spectroscopic and polarization imaging to better evaluate the composition of tissues and lesions.
• Small Size: The fiber-based design allows easy integration with small handpiece size scanners for easy access to the mouth.
• No Ionization (Radiation): Frequency of light used is safe for biological tissue.
• No Imaging Preparation: No time wasted preparing a dry field or removing stain/plaque to perform imaging.
• Portable and Upgradeable: System is PC based, portable, easily upgraded and integrates well with existing office applications.
• Real Time Imaging: Imaging is at or near real time.

Disclosure: Pentony Enterprises LLC was compensated $27,000 and 70,000 restricted shares directly from the company and 55,000 free trading shares from a non controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. It is the policy of Pentony Enterprises LLC to sell all shares of this and any company featured. Anyone considering any company we feature in consideration for free trading shares should consider this. Pentony Enterprises no longer holds shares.

Management

Stanley Baron Chairman, President & CEO

Stanley Baron has extensive international business experience. He has over the years demonstrated his ability to predict market trends and has started and successfully positioned several companies to meet the needs of changing markets. In 1971 in Zimbabwe (Rhodesia) he founded a consumer products wholesale distribution business. The company prospered despite the civil war and within a few years it expanded rapidly to become the largest distributor of packaged foods in Zimbabwe, with sales approaching $100 million annually. The Company was subsequently sold to Metro, a large European food company.

Baron and his family immigrated to Israel in 1979. He purchased a partnership in a small dental equipment company that represented Adec, the leading US dental equipment manufacturer, as well as other American, European and Japanese companies. The company grew rapidly and within three years became the leading dental equipment company in Israel. Capitalizing on the opportunity to be a full service dental distributor, Baron merged with then largest sundry distributor Healthco (Israel), a subsidiary of Healthco International, at that time the largest dental company in the world. Under Baron's management, Healthco (Israel) grew rapidly and with annual sales of $8 million and a staff of 40, became the leading dental distributor in Israel.

In 1989 Baron moved to the US and started to work with dental companies to identify, license and commercialize new technologies. He was involved in several successful projects. Stan Baron has developed a keen sense for the technology needs of dentistry and has a network of sources. He has extensive experience in the many areas of products and equipment that are used in dentistry and the modalities that comprise the digital dental office. Baron's business skills, coupled with his ability to determine trends, and understand technology application in the dental field, makes him invaluable to the success of the Company.

Craig Gimbel, D.D.S. Executive Vice-President of Clinical Affairs, Director

Craig Gimbel is a recognized authority in laser/photonics and other high technology. After graduating from New York University College of Dentistry in 1977, he practiced clinical dentistry and worked on numerous dental technology projects which included clinical research, publishing and teaching. In 2005, Dr. Gimbel left clinical private practice in order to give Lantis his full time attention.

Gimbel has over 16 years of clinical and research experience in laser/photonic dentistry. He is responsible for developing the applications and the technique required to use laser technology in an efficacious and safe manner. Dr. Gimbel has successfully trained dentists throughout the world in its use, is widely published and wrote the first textbook chapter in the clinical use of laser cavity preparation in Dental Clinics of North America in 2000. Dr. Gimbel was Principal Investigator for the first FDA human hard tissue clinical trials of the Er:YAG laser from 1993 to 1997. He is a past Chairperson of the Scientific Committee of the Academy of Laser Dentistry and had achieved Advanced Proficiency Certification in Laser Dentistry in 1993. Presently, Gimbel is Conference Committee Chair and will become President of the Academy of Laser Dentistry in March 2007. While he was Chair of the Regulatory Affairs Committee, Gimbel was responsible for state dental board acceptance of educational standards. He was invited in 1996 to speak on behalf of NASA (National Aeronautics and Space Administration) at the American Dental Association-NASA Dental Industry Technology Forum. He is a Fellow of the American College of Dentists, American Society of Dentistry for Children, Academy of General Dentistry and Academy of Dentistry International. He has appeared on numerous television programs, including Dateline NBC, to discuss new technologies in dentistry and has published and presented worldwide on the integration of emerging high technology in dentistry. Dr. Gimbel has been a visionary of the digital dental office and other high technologies in dentistry as far back as 27 years ago.

Gimbel is the 2003 recipient of the prestigious T. H. Maiman Award for Excellence in Dental Laser/Photonics Research. His experience as a Principal Investigator for the Erbium:YAG laser and numerous other technologies for dentistry is invaluable for the clinical development of the Company’s products. His “hands-on” clinical experience and recognition in the dental profession is an asset to the company. Dr. Gimbel’s crossover knowledge of the dental industry and the needs of the practicing dentist is a valuable asset for Lantis’ product development.

Doug Hamilton Vice President of Research & Development

Doug Hamilton has extensive experience in the development of optical products. As former President and Director of Operations of Aries International Inc., he is “solutions oriented” with invaluable experience in “hands on” project team management including systems development and integration of optical, digital and radiographic products. He has successfully developed over 14 hardware and software products for industrial and medical markets with his specialty being image capture, processing, manipulation and storage. A large part of his experience was in the NDE industry where his experience also included contract development and contract negotiations for manufacturing. Among his major clients were DuPont, Siemens, TVA, Duke University, and the National Institute of Environmental Health. He has successfully designed and built the system prototypes for the OCT System and probe/scanner that forms the platform for Lantis’ OCT imaging system.

Linda Otis, D.D.S. Vice President of Clinical Research

Linda Otis is currently Professor of Oral and Maxillofacial Radiology at the University of Maryland, Baltimore College of Dental Surgery, in Baltimore, Maryland. She received her D.D.S. at University of Nebraska, Lincoln and did her postgraduate work in diagnostic science at University of Texas, San Antonio.

Dr. Otis initiated the application of OCT for use in dentistry while she was at the University of California, San Francisco Dental School in 1994 and implemented the research on OCT with the Medical Technology Program scientists at Lawrence Livermore National Laboratory. The results of this pioneering research were published in numerous articles showing that OCT could be used for the early detection of oral diseases in hard and soft tissue. She is the foremost authority on OCT and is active in research relating to new methods for diagnosing common oral conditions as a principal investigator of a National Institute of Health research grant.

A renowned speaker, Dr. Otis has lectured throughout the United States on many topics in dentistry. She has published widely, including 35 publications and many published abstracts. She is named on three of the patents relating to OCT application in dentistry.

Disclosure: Pentony Enterprises LLC was compensated $27,000 and 70,000 restricted shares directly from the company and 55,000 free trading shares from a non controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. It is the policy of Pentony Enterprises LLC to sell all shares of this and any company featured. Anyone considering any company we feature in consideration for free trading shares should consider this. Pentony Enterprises no longer holds shares.

Disclosure: Pentony Enterprises LLC was compensated $27,000 and 70,000 restricted shares directly from the company and 55,000 free trading shares from a non controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. It is the policy of Pentony Enterprises LLC to sell all shares of this and any company featured. Anyone considering any company we feature in consideration for free trading shares should consider this. Pentony Enterprises no longer holds shares.

Contact Info

Lantis Laser Inc.

11 Stonebridge Court
Denville, NJ 07834

Phone:

(203) 300-7622

Fax:

(619) 789-0454

Email:

info@lantislaser.com (general)
Stan Baron, CEO: sbaron@lantislaser.com (management and company matters)

Website:

www.lantislaser.com

Disclosure: Pentony Enterprises LLC was compensated $27,000 and 70,000 restricted shares directly from the company and 55,000 free trading shares from a non controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. It is the policy of Pentony Enterprises LLC to sell all shares of this and any company featured. Anyone considering any company we feature in consideration for free trading shares should consider this. Pentony Enterprises no longer holds shares.